Literature DB >> 18345479

The urokinase receptor and integrins in cancer progression.

C-H Tang1, Y Wei.   

Abstract

Enhanced levels of expression of urokinase receptor (uPAR) and certain integrins have been linked to cancer cell progression. This has classically been attributed to matrix degradation via the activation of the urokinase (uPA)/plasmin system and modulation of cell motility and survival through integrin engagement. More recently, uPAR has been shown to play multiple roles independent of protease activity. Specifically, uPAR has been shown to be intimately involved in the regulation of cell adhesion, migration and proliferation in part through interactions with other membrane partners, including integrins. The goal of this review is to summarize recent insights in the function of uPAR/integrin interactions, to provide a framework for understanding the importance of these interactions in the context of cancer, and to highlight its potential as a target for therapeutic intervention.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18345479     DOI: 10.1007/s00018-008-7573-9

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  24 in total

1.  Urinary-type plasminogen activator receptor (uPAR) modulates oral cancer cell behavior with alteration in p130cas.

Authors:  Zonggao Shi; Yueying Liu; Jeffrey J Johnson; M Sharon Stack
Journal:  Mol Cell Biochem       Date:  2011-06-01       Impact factor: 3.396

Review 2.  Integrin α3β1 as a breast cancer target.

Authors:  Sita Subbaram; C Michael Dipersio
Journal:  Expert Opin Ther Targets       Date:  2011-08-13       Impact factor: 6.902

3.  The dual role of TLR3 in metastatic cell line.

Authors:  Tanja Matijevic; Jasminka Pavelic
Journal:  Clin Exp Metastasis       Date:  2011-07-07       Impact factor: 5.150

4.  Role of integrins in regulating proteases to mediate extracellular matrix remodeling.

Authors:  Jiao Yue; Kun Zhang; Jianfeng Chen
Journal:  Cancer Microenviron       Date:  2012-03-22

5.  Secretory leukocyte protease inhibitor (SLPI) expression and tumor invasion in oral squamous cell carcinoma.

Authors:  Jie Wen; Nikolaos G Nikitakis; Risa Chaisuparat; Teresa Greenwell-Wild; Maria Gliozzi; Wenwen Jin; Azita Adli; Niki Moutsopoulos; Tanxia Wu; Gary Warburton; Sharon M Wahl
Journal:  Am J Pathol       Date:  2011-06       Impact factor: 4.307

6.  ECRG2 regulates cell migration/invasion through urokinase-type plasmin activator receptor (uPAR)/beta1 integrin pathway.

Authors:  Xiaolong Cheng; Zheng Shen; Litian Yin; Shih-Hsin Lu; Yongping Cui
Journal:  J Biol Chem       Date:  2009-08-28       Impact factor: 5.157

7.  Participation of the urokinase receptor in neutrophil efferocytosis.

Authors:  Young-Jun Park; Gang Liu; Yuko Tsuruta; Emmanuel Lorne; Edward Abraham
Journal:  Blood       Date:  2009-04-27       Impact factor: 22.113

8.  The urokinase receptor supports tumorigenesis of human malignant pleural mesothelioma cells.

Authors:  Torry A Tucker; Candice Dean; Andrey A Komissarov; Kathy Koenig; Andrew P Mazar; Usha Pendurthi; Timothy Allen; Steven Idell
Journal:  Am J Respir Cell Mol Biol       Date:  2009-07-27       Impact factor: 6.914

Review 9.  Endocytosis of glycosylphosphatidylinositol-anchored proteins.

Authors:  Shaheen E Lakhan; Shefali Sabharanjak; Ananya De
Journal:  J Biomed Sci       Date:  2009-10-15       Impact factor: 8.410

10.  Co-detection of members of the urokinase plasminogen activator system in tumour tissue and serum correlates with a poor prognosis for soft-tissue sarcoma patients.

Authors:  H Taubert; P Würl; T Greither; M Kappler; M Bache; C Lautenschläger; S Füssel; A Meye; A W Eckert; H-J Holzhausen; V Magdolen; M Kotzsch
Journal:  Br J Cancer       Date:  2010-01-05       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.